Literature DB >> 20012869

Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

Thomas A O'Bryan1, Stanley J Naides.   

Abstract

Human parvovirus B19 (B19) infection is often suspected as an etiologic agent in a variety of rheumatologic diseases. It has been hypothesized that this virus potentially induces immune dysregulation by abnormal cytokine expression in susceptible hosts. The objective of this study is to examine the relationship between anti-parvovirus B19 IgG antibody (B19 IgG) and two common markers of immune dysregulation-antinuclear antibody (ANA) and C-reactive protein (CRP) in clinical sera. Qualitative B19 IgG antibody and levels of high-sensitivity CRP were determined in adult serum samples submitted to a university hospital clinical laboratory for ANA testing. Prevalence of B19 IgG was compared among groups by ANA status and CRP tertile. B19 IgG was detected in 72.3% of 318 samples. Among women above the first quartile of age (>38 years), presence of B19 IgG was associated with CRP tertile rank (P = 0.008) and CRP levels > or =1 mg/L (P = 0.001) independent of age and ANA status. B19 IgG was less frequent in ANA-positive than ANA-negative women < or =38 years of age (P = 0.009). Viral antibody was not associated with either biomarker in men. These data suggest parvovirus B19 infection may be associated with chronic inflammation in some women after the third decade of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012869     DOI: 10.1007/s00296-009-1262-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  The effect of infections on susceptibility to autoimmune and allergic diseases.

Authors:  Jean-Francois Bach
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

4.  Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.

Authors:  Yi Fu; Keiko Kumura Ishii; Yasuhiko Munakata; Takako Saitoh; Mitsuo Kaku; Takeshi Sasaki
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 5.  Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?

Authors:  Leslie Ann Mitchell
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

6.  Antinuclear antibody testing. A study of clinical utility.

Authors:  C A Slater; R B Davis; R H Shmerling
Journal:  Arch Intern Med       Date:  1996-07-08

7.  Exposure to infant siblings during early life and risk of multiple sclerosis.

Authors:  Anne-Louise Ponsonby; Ingrid van der Mei; Terence Dwyer; Leigh Blizzard; Bruce Taylor; Andrew Kemp; Rex Simmons; Trevor Kilpatrick
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

8.  A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

Authors:  S Moffatt; N Tanaka; K Tada; M Nose; M Nakamura; O Muraoka; T Hirano; K Sugamura
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 9.  Epidemiological and immunological evidence for the hygiene hypothesis.

Authors:  Holger Garn; Harald Renz
Journal:  Immunobiology       Date:  2007-04-30       Impact factor: 3.144

10.  Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

Authors:  Adiba Isa; Victoria Kasprowicz; Oscar Norbeck; Andrew Loughry; Katie Jeffery; Kristina Broliden; Paul Klenerman; Thomas Tolfvenstam; Paul Bowness
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.